Kinetic study of the processing by dipeptidyl‐peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion

[1]  C. Durinx,et al.  Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine Family* , 2001, The Journal of Biological Chemistry.

[2]  J. Holst,et al.  Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs. , 2001, Diabetes.

[3]  Z. Zukowska,et al.  Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding , 2001, Peptides.

[4]  R. Pederson,et al.  Metabolism of glucagon by dipeptidyl peptidase IV (CD26) , 2001, Regulatory Peptides.

[5]  N. Sherwood,et al.  THE ORIGIN AND FUNCTION OF THE PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)/GLUCAGON SUPERFAMILY , 2000 .

[6]  Annick Thomas,et al.  Identification of Key Residues for Interaction of Vasoactive Intestinal Peptide with Human VPAC1 and VPAC2Receptors and Development of a Highly Selective VPAC1Receptor Agonist , 2000, The Journal of Biological Chemistry.

[7]  J. Holst,et al.  In vivo and in vitro degradation of glucagon-like peptide-2 in humans. , 2000, The Journal of clinical endocrinology and metabolism.

[8]  D. Marguet,et al.  Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Ahrén.  Autonomic regulation of islet hormone secretion – Implications for health and disease , 2000, Diabetologia.

[10]  R A Pederson,et al.  Dipeptidyl Peptidase IV (DPIV/CD26) Degradation of Glucagon , 2000, The Journal of Biological Chemistry.

[11]  Rolf Mentlein,et al.  Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides , 1999, Regulatory Peptides.

[12]  J. Holst,et al.  Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7–36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats , 1999, Diabetologia.

[13]  I. De Meester,et al.  CD26, let it cut or cut it down. , 1999, Immunology today.

[14]  N. Hooper,et al.  Specific Localization of Membrane Dipeptidase and Dipeptidyl Peptidase IV in Secretion Granules of Two Different Pancreatic Islet Cells , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  R. Pederson,et al.  Improved Glucose Tolerance in Zucker Fatty Rats by Oral Administration of the Dipeptidyl Peptidase IV Inhibitor Isoleucine Thiazolidide , 1998, Diabetes.

[16]  Laura H. Tang,et al.  Gastrin and the Enterochromaffin-Like Cell: An Acid Update , 1998, Digestive Surgery.

[17]  J. Holst,et al.  Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. , 1998, Diabetes.

[18]  J. V. Van Beeumen,et al.  A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma. , 1997, Biochimica et biophysica acta.

[19]  D. Drucker,et al.  Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV , 1997, Nature Biotechnology.

[20]  R. Pederson,et al.  Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. , 1995, Endocrinology.

[21]  Daniel Grandt,et al.  Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV , 1993, Regulatory Peptides.

[22]  T. Kubiak,et al.  Dipeptidyl peptidase IV (DPP-IV) from pig kidney cleaves analogs of bovine growth hormone-releasing factor (bGRF) modified at position 2 with Ser, Thr or Val. Extended DPP-IV substrate specificity? , 1993, Biochimica et biophysica acta.

[23]  B. Gallwitz,et al.  Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. , 1993, European journal of biochemistry.

[24]  E. Heimer,et al.  Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs. , 1992, Biochimica et biophysica acta.

[25]  P. de Neef,et al.  Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes. , 1991, European journal of biochemistry.

[26]  M. Hegen,et al.  The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. , 1990, Journal of immunology.

[27]  R. Mentlein,et al.  The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta. , 1990, Biological chemistry Hoppe-Seyler.

[28]  R. Jensen,et al.  Interaction of Bombesin and Related Peptides with Receptors on Pancreatic Acinar Cells , 1988, Annals of the New York Academy of Sciences.

[29]  J. Holst,et al.  Role of gastrin-releasing peptide in pepsinogen secretion from the isolated perfused rat stomach , 1988, Regulatory Peptides.

[30]  L. Thim,et al.  Molecular forms of katacalcin, calcitonin gene-related peptide and gastrin-releasing peptide, in a human medullary thyroid carcinoma. , 1988, Cancer research.

[31]  A. Shulkes,et al.  Hepatic metabolism of vasoactive intestinal polypeptide (VIP) in the rat , 1988, Regulatory Peptides.

[32]  F. L. Hill,et al.  Distribution of bombesin-like peptides in the alimentary canal of several vertebrate species , 1986, Regulatory Peptides.

[33]  J. Shively,et al.  Isolation and sequence analysis of human bombesin-like peptides , 1984, Peptides.

[34]  D. Hawke,et al.  Amino acid sequences of three bombesin-like peptides from canine intestine extracts. , 1983, The Journal of biological chemistry.

[35]  G. Püschel,et al.  Isolation and characterization of dipeptidyl peptidase IV from human placenta. , 1982, European journal of biochemistry.

[36]  S. Bloom,et al.  Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. , 1978, Gut.

[37]  V. Mutt,et al.  A gastrin releasing peptide from the porcine nonantral gastric tissue. , 1978, Gut.

[38]  J. Yon,et al.  Enzyme Kinetics behavior and Analysis of rapid equilibrium and steady state enzyme systems, I.H. Segel. John Wiley, London (1975) , 1976 .

[39]  I. H. Segel.  Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .